Heinemann, V; von Weikersthal, LF; Fuchs, M; Kaiser, F; Heinrich, K; Modest, D; Hofheinz, R; Decker, T; Gerger, A; Angermeier, S; Rumpold, H; Dickhut, A; Ohler, L; Grunberger, B; Niedersuss-Beke, D; Sandmann, M; Kasper, S; Prager, G; Stintzing, S.
FIRE-4 (AIO-KRK-0114): Randomized study for a switch maintenance concept with 5-FU plus bevacizumab after induction treatment with FOLFIRI plus cetuximab versus continued treatment with FOLFIRI plus cetuximab - secondary endpoint
ANN ONCOL. 2022; 33: S363-S364.
Doi: 10.1016/j.annonc.2022.04.415
[Poster]
Web of Science
FullText
FullText_MUG